Pricing Log in Create free account

CytomX Therapeutics, Inc. (CTMX) vs Shattuck Labs, Inc. (STTK)

CytomX Therapeutics, Inc. and Shattuck Labs, Inc. are both Biotechnology companies. CytomX Therapeutics, Inc. and Shattuck Labs, Inc. are of similar size ($555.0M and $525.1M). Shattuck Labs, Inc. grew revenue faster over the last twelve months: 106.5% against −87.0%. Shattuck Labs, Inc. has the higher net margin (0.00% vs −451.6%) and the lower return on invested capital (−1,230.7% vs 0.00%). Across the 16 metrics below, Shattuck Labs, Inc. leads on 9 and CytomX Therapeutics, Inc. on 7.

Valuation

Metric CTMX STTK Biotechnology median
P/E n/m n/m 8.50
P/S 27.16 125.47 9.71
P/B 1.65 3.33 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA n/m n/m 0.64
EV/Sales 9.28 88.32 9.21
Earnings yield (22.03%) (9.41%) (33.15%)
Free cash flow yield (16.63%) (5.86%) (25.50%)

Profitability

Metric CTMX STTK Biotechnology median
Gross margin 100.00% 100.00% 65.16%
Operating margin (476.19%) 0.00% 0.00%
Net margin (451.62%) 0.00% 0.00%
Free cash flow margin (450.27%) 0.00% 0.00%
Return on equity (39.18%) (39.21%) (56.36%)
Return on assets (29.72%) (36.88%) (48.04%)
Return on invested capital 0.00% (1,230.74%) 0.00%

Growth

Metric CTMX STTK Biotechnology median
Revenue growth (TTM) (87.03%) 106.48% 6.02%
EPS growth (last fiscal year) (139.47%) 53.02% 30.26%
Revenue growth, 5-year CAGR (5.36%) (36.82%) 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric CTMX STTK Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 9.36 27.59 4.72
Net debt to EBITDA 5.91 1.62 0.96

Dividend

Metric CTMX STTK Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric CTMX STTK Biotechnology median
Market cap 525.14m 555.01m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack